Treatment of uremic hypertriglyceridaemia with bezafibrate

Elevated triglycerides (TG) in serum and in very low density lipoproteins (VLDL), and a high cholesterol concentration in VLDL but low concentration in high density lipoproteins (HDL), are some characteristics of chronic, non-nephrotic renal failure (CRF). We have given the clofibrate analogue bezaf...

Full description

Saved in:

Bibliographic Details
Published in:	Atherosclerosis 1982-08, Vol.44 (2), p.125-136
Main Authors:	Norbeck, Hans-Erik, Anderson, Per
Format:	Article
Language:	eng
Subjects:	Bezafibrate Cholesterol - blood Clofibrate - analogs & derivatives Clofibric Acid - analogs & derivatives Clofibric Acid - therapeutic use Female Humans Hyperlipidaemia Hyperlipidemias - drug therapy Kidney Failure, Chronic - blood Kidney Failure, Chronic - metabolism Lipid Metabolism Lipoproteins - blood Male Renal failure Serum lipoproteins Triglycerides - blood
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Elevated triglycerides (TG) in serum and in very low density lipoproteins (VLDL), and a high cholesterol concentration in VLDL but low concentration in high density lipoproteins (HDL), are some characteristics of chronic, non-nephrotic renal failure (CRF). We have given the clofibrate analogue bezafibrate in a reduced dosage, calculated from individual single dose administrations of bezafibrate, to 12 patients with CRF, to treat their abnormal lipid levels. Serum TG were lowered by 40% due to a decrease in the VLDL fraction by 49%. High levels of LDL cholesterol were lowered, while low levels increased during treatment. HDL cholesterol increased by 17%. Studies of the removal rate of TG-rich particles from the blood and of adipose tissue metabolism could not explain the changes in serum lipids. No subjective or objective side effects from the drug were seen. An individualized dosage of bezafibrate and repeated checks of the serum concentrations of the drug are recommended during long-term treatment of uremic patients.
ISSN:	0021-9150 1879-1484